Impact of Liver Transplantation on Sexual Life and Function
NCT ID: NCT07268196
Last Updated: 2025-12-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
100 participants
OBSERVATIONAL
2025-12-07
2026-10-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Chronic liver Disease
Chronic Liver disease patients undergoing elective liver transplantation
No Treatment
This is an Observational Study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No Treatment
This is an Observational Study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Decompensated Chronic Liver Disease awaiting elective liver transplantation.
3. Post Liver Transplant patients with stable graft function.
Exclusion Criteria
2. Patients with ongoing medical and surgical issues (biliary complications, graft complication etc.).
3. Acute on Chronic Liver Failure and Acute Liver Failure patients.
18 Years
60 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institute of Liver and Biliary Sciences, India
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Prof. Dr. Viniyendra Pamecha, MS FEBS
Role: STUDY_DIRECTOR
ILBS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ILBS
New Delhi, National Capital Territory of Delhi, India
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Dr. Rajagopalan G, DNB
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IEC/2024/110/MA03
Identifier Type: -
Identifier Source: org_study_id